Revive Therapeutics (XCNQ:RVV) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Revive Therapeutics's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Revive Therapeutics's long-term debt to total assets ratio declined from Sep. 2022 (0.01) to Dec. 2023 (0.01). It may suggest that Revive Therapeutics is progressively becoming less dependent on debt to grow their business.

Revive Therapeutics LT-Debt-to-Total-Asset Historical Data

The historical data trend for Revive Therapeutics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics LT-Debt-to-Total-Asset Chart

Revive Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.05

0.01

Revive Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	-	0.01

Revive Therapeutics LT-Debt-to-Total-Asset Calculation

Revive Therapeutics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

LT Debt to Total Assets (A: Jun. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2023 )	/	Total Assets (A: Jun. 2023 )
	=	0.085	/	14.252
	=

Revive Therapeutics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.06	/	12.877
	=

Revive Therapeutics (XCNQ:RVV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Revive Therapeutics LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (XCNQ:RVV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

RVVTF:USA 31R:Germany

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Executives

Michael Frank

Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines